DEXAMETHASONE SODIUM PHOSPHATE Drug Patent Profile
✉ Email this page to a colleague
When do Dexamethasone Sodium Phosphate patents expire, and what generic alternatives are available?
Dexamethasone Sodium Phosphate is a drug marketed by Amneal, Bel Mar, Dell Labs, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Geneyork Pharms, Gland Pharma Ltd, Hikma, Intl Medication, Luitpold, Lyphomed, Mylan Labs Ltd, Somerset, Somerset Theraps Llc, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, Sola Barnes Hind, Bausch And Lomb, and Sandoz. and is included in forty NDAs.
The generic ingredient in DEXAMETHASONE SODIUM PHOSPHATE is dexamethasone sodium phosphate. There are thirty-nine drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the dexamethasone sodium phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dexamethasone Sodium Phosphate
A generic version of DEXAMETHASONE SODIUM PHOSPHATE was approved as dexamethasone sodium phosphate by WEST-WARD PHARMS INT on September 7th, 1982.
Summary for DEXAMETHASONE SODIUM PHOSPHATE
US Patents: | 0 |
Applicants: | 23 |
NDAs: | 40 |
Finished Product Suppliers / Packagers: | 17 |
Raw Ingredient (Bulk) Api Vendors: | 87 |
Clinical Trials: | 64 |
Patent Applications: | 4,395 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DEXAMETHASONE SODIUM PHOSPHATE at DailyMed |
Recent Clinical Trials for DEXAMETHASONE SODIUM PHOSPHATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
AbbVie | Phase 1 |
Andrew E. Place | Phase 1 |
Children's Cancer Research Fund | Phase 1 |
Pharmacology for DEXAMETHASONE SODIUM PHOSPHATE
Drug Class | Corticosteroid |
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for DEXAMETHASONE SODIUM PHOSPHATE
US Patents and Regulatory Information for DEXAMETHASONE SODIUM PHOSPHATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Somerset Theraps Llc | DEXAMETHASONE SODIUM PHOSPHATE PRESERVATIVE FREE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 207442-001 | Apr 19, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
West-ward Pharms Int | DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 087702-001 | Sep 7, 1982 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Watson Labs | DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 084355-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | DEXAMETHASONE SODIUM PHOSPHATE | dexamethasone sodium phosphate | INJECTABLE;INJECTION | 085641-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |